The American Society of Hematology will hold its 53rd annual meeting this Saturday, December 10, through Tuesday, December 13, in San Diego.
Medical professionals will gather during the four-day meeting to discuss the latest findings for various blood diseases, including myelodysplastic syndromes (MDS).
The American Society of Hematology (ASH) meeting includes education and scientific sessions, poster viewings, and oral presentations, as well as meet-the-expert opportunities.
The latest MDS research findings will be discussed in over 50 oral presentations and more…
Ellen O’Neill, a native of Bray on the eastern coast of Ireland, works in home help in addition to caring for her elderly father.
However, she herself became the patient in May 2005 when she was diagnosed with myelodysplastic syndromes (MDS) at the age of 50.
That May, O’Neill began having hot flashes, flu-like symptoms, and fatigue. She attributed the symptoms to menopause and went to see her doctor in October 2005 for blood tests and to discuss starting hormone…
New research from Japan indicates that low levels of the blood protein ferritin are associated with better outcomes in myelodysplastic syndromes (MDS) patients who undergo stem cell transplantation.
“In both [standard- and high-risk] MDS, elevated ferritin has a negative effect on the outcomes of transplantation,” said study author Dr. Takayoshi Tachibana of the Yokohama City University Medical Center in Yokohama, Japan.
Dr. Tachibana pointed out that patients with elevated ferritin levels should nevertheless undergo stem cell transplantation because “We think…
Recent research from Italy indicates that myelodysplastic syndromes patients with mutations in the SF3B1 gene may have a better prognosis than patients without the mutation.
The research also indicates that patients with mutations in the SF3B1 gene are more likely to have a specific type of abnormal red blood cell in their bone marrow.
Based on their findings, the study authors conclude that mutations on the SF3B1 gene, along with other genetic mutations, may help improve the determination of prognosis…